NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Jan. 07, 2019	Jan. 31, 2019	Jun. 30, 2019	Jun. 30, 2018
State of incorporation			Nevada
Date of incorporation			Feb. 21, 2014
Proceeds from issuance of convertible notes			$ 389,939	$ 29,500
Net loss			(507,928)	(401,757)
Net cash used in operating activities			$ (399,043)	$ (162,036)
Issuance of common stock for cash, shares
Trace Analytics [Member]
Common stock purchase agreement, description	On January 7, 2019, the Company closed on a purchase of 520,410 shares of common stock of Trace Analytics, Inc., a Washington corporation (“Trace Analytics”). Pursuant to a Common Stock Purchase Agreement, the Company purchased Trace Analytics at a purchase price of $2.40 per share, for an aggregate purchase price of $1,250,000, of which $750,000 was paid in cash and $500,000 was paid through the issuance of shares of the Company’s common stock.	the Company closed on a purchase of 520,410 shares of common stock of Trace Analytics, Inc., a Washington corporation (“Trace Analytics”), for an aggregate purchase price of $1,250,000, of which $750,000 was paid in cash and $500,000 was paid in shares of common stock of the Company. Trace Analytics is a cannabis testing laboratory. Immediately following the purchase, the Company held 51% of the issued and outstanding shares of common stock
Issuance of common stock for cash, shares	520,410	520,410
Aggregate purchase price of common stock	$ 1,250,000	$ 1,250,000
Purchase price of common stock paid in cash	$ 750,000	$ 750,000
Purchase price of common stock paid in shares	500,000	500,000
Owned interest entity			51.00%
Private Placements [Member] | Accredited Investors [Member]
Proceeds from issuance of convertible notes			$ 1,600,000